Navigation Links
Novogen Announces Results of General Meeting of Shareholders
Date:8/13/2014

SYDNEY, Aug. 13, 2014 /PRNewswire/ -- Australia-US biotechnology company, Novogen Ltd. (ASX: NRT, NASDAQ: NVGN), an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia. A total of 28.3M shares were represented in person or by proxy at the meeting, during which the following resolutions were passed (95% in favor):

RESOLUTION 1.
SUBSEQUENT APPROVAL OF ISSUE OF CONVERSION SHARES
"That for the purposes of Listing Rule 7.1 and for all other purposes, subsequent approval is given under Listing Rule 7.4 to the allotment and issue of the Conversion Shares as described in the Explanatory Statement."

RESOLUTION 2.  APPROVAL OF ISSUE OF NEW SHARES AND ATTACHING WARRANTS
"That, for the purposes of Listing Rule 7.1 and section 50.1 of the Company's Constitution and for all other purposes, approval is given to the increase of the capital of the Company through the issue of up to 80 million New Shares and up to 80 million attaching Warrants in order for the Company to raise up to approximately $20 million on the terms described in the Explanatory Statement."

Graham Kelly PhD, Novogen Group CEO and Executive Chairman, said, "These two resolutions are about providing the Board with the capacity to raise the working capital Novogen needs to bring up to 3 drug candidates into the clinic. The approved resolutions now give the Board the flexibility to tailor capital-raisings to specific requirements according to when the capital is required and in response to market conditions."

"The first product we need to support is Cantrixil, the outcome of the Novogen-Yale joint venture company, CanTx Inc. We currently are making this product ready for the clinic with the a
'/>"/>

SOURCE Novogen Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy
2. Top Active Companies to Watch: Crown Marketing, Herbalife, Novogen, GNC, Pfizer and Infinity Pharmaceuticals
3. Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares
4. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
5. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
6. Ambit Biosciences Announces Second Quarter 2014 Operating Results
7. GRANDCARE SYSTEMS Announces Significant Investment in Professional Caregiving Sales Program
8. BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on Track following Pre-NDA Meeting with FDA
9. Mindray Announces Second Quarter 2014 Financial Results
10. Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update
11. Dynatronics Announces Completion of $3.8 Million Sale and Leaseback Transaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , March 6, 2015 Lucerne Biosciences, ... Office,s publication of U.S. Patent Application No. 14/464,249 ... Patent Application features claimed methods of "informing a ... to treat Binge Eating Disorder (,BED,)," including by ... "flyer or an advertisement," as well as by ...
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)...  IRIDEX Corporation (Nasdaq: IRIX ) today reported ... 3, 2015.  , Revenues were $11.8 million in ... and up 11% from $10.6 million in the 2013 fourth ... up 12% from $38.3 million in 2013. , Gross ... 48.6% in the fourth quarter of the prior year. ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8
... ... 15 SRI International, an independent nonprofit research and development organization, ... bioadhesive drug delivery system that enables enhanced release of drugs through ... drug delivery and allows for a much longer release time compared ...
... , KNOXVILLE, Tenn., Dec. 15 Medical researchers with EDP ... new technology for a simple blood test to detect early-stage ... pre-clinical trials for the ColoMarker(TM) assay, EDP has filed a ... use. Via an inexpensive blood test, ColoMarker(TM) will detect ...
Cached Medicine Technology:SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2
(Date:3/6/2015)... 06, 2015 Los Angeles cosmetic dentist ... for Zoom whitening. Zoom is a special type of teeth ... Unlike other teeth whitening treatments, Zoom does its job in ... stains. For a limited time, Dr. Ghasri is offering Zoom ... usual price of $650 and allows patients to try out ...
(Date:3/6/2015)... March 06, 2015 Medical Products, Inc., ... an agreement with GE Healthcare to become an authorized ... United States. , MPI has 31 years in distribution ... Healthcare. , With this agreement, MPI will have the ... the healthcare industry. , MPI has always strived ...
(Date:3/5/2015)... (PRWEB) March 06, 2015 In 2014, ... being first–in-class. AstraZeneca tops the list scoring 4 drug ... over 25% of all FDA approved drug products, followed ... mechanisms such as anti-PCSK9, anti-PD1 and CDK inhibitors keep ... approved by the FDA to treat metastatic melanoma, and ...
(Date:3/5/2015)... March 05, 2015 A Bakersfield, Calif. state ... seven-week trial awarding the plaintiff Coleen M. Perry a ... result of a TVT-Abbrevo pelvic mesh sling device, manufactured by ... Tom Cartmell , a partner at Wagstaff & Cartmell ... for the plaintiff, along with Rich Freese and Tim Goss ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to ... new logo and optimized website. , CNI’s ... to expert diagnostic imaging, centered on patient care. The ... be a resource for Nebraska patients and a tool ... and referral functionality, video content and resources to understand ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Central Nebraska Imaging Center Gets Rebranding 2
... A study of 62 youngsters has revealed that low tar, ... severely as regular cigarettes . ,All the participants ... Heart, were in their mid-twenties. ,Twenty of them ... three years, while 20 other participants had smoked regular cigarettes ...
... A new research has found that extremely anxious patients with ... or death when compared to those with a calmer ... time were in greatest danger, while those who initially had ... their risk. ,"Most patients come in very anxious ...
... a solution for the embarrassing problem of bad breath or ... paste that can tackle separate causes of smelly breath. ... dihydrogen sulphide, which can lead to bad breath, reports the ... enzyme that fights starch and cellulose in between the teeth ...
... have higher dietary intake of foods with omega-3 fatty acids ... age-related macular degeneration, while those with higher serum levels ... early stages of the disease, according to two reports in ... JAMA/Archives journals. ,Age-related macular degeneration (AMD) occurs when ...
... surgical removal of the prostate due to cancer may ... not worry about the post-surgical urinary incontinence. ... at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has devised a ... ensure continence. ,They describe the success of ...
... to take a heavy toll the world over. Almost 100 million ... as infants. ,According to a searing report on the ... the increase in many developing countries, where a male child ... International - a global child development agency - highlights the fact ...
Cached Medicine News:Health News:Risk of Heart Attack, Death High Among Extremely Anxious Patients 2Health News:Risk of Heart Attack, Death High Among Extremely Anxious Patients 3Health News:Higher Intake of Fish and Vitamin D Reduces the Risk of Age-related Macular Disease 2Health News:Higher Intake of Fish and Vitamin D Reduces the Risk of Age-related Macular Disease 3Health News:Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy 2Health News:Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy 3Health News:Female Infanticide and Feticide Continue to Increase 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: